These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3898652)

  • 1. [Significance of antithrombin III in clinical liver transplantations].
    Lohse W; Winkler H; Wolff H
    Zentralbl Chir; 1985; 110(13):803-10. PubMed ID: 3898652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin cofactor II deficiency in renal allograft recipients: no correlation with the development of thrombosis.
    Toulon P; Moulonguet-Doleris L; Costa JM; Aiach M
    Thromb Haemost; 1991 Jan; 65(1):20-4. PubMed ID: 2024235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
    Finazzi G; Barbui T
    Thromb Haemost; 1994 Jan; 71(1):15-8. PubMed ID: 8165635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of antithrombin III in patients undergoing orthotopic liver transplantation after administration of an antithrombin III concentrate.
    Scherer RU; Gödde S; Giebler RM; Schmutzler MJ; Erhard J; Kox WJ
    Semin Thromb Hemost; 1993; 19(3):309-10. PubMed ID: 8362259
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
    Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living related liver transplantation for acute liver failure in children.
    Emre S; Schwartz ME; Shneider B; Hojsak J; Kim-Schluger L; Fishbein TM; Guy SR; Sheiner PA; LeLeiko NS; Birnbaum A; Suchy FJ; Miller CM
    Liver Transpl Surg; 1999 May; 5(3):161-5. PubMed ID: 10226105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III screening: necessity or extravagance.
    Taberner DA
    Med Lab Sci; 1984 Jul; 41(3):262-6. PubMed ID: 6482694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical manifestation and patho-typing of biliary cast syndrome in patients after orthotopic liver transplantation].
    Zhu XD; Shen ZY; Chen XG; Zang YJ
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):728-32. PubMed ID: 18953924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thromboembolism. The clinical significance of antithrombin III].
    Schramm W
    Internist (Berl); 1984 Feb; 25(2):88-92. PubMed ID: 6368458
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)].
    Thaler E
    Wien Klin Wochenschr; 1981 Oct; 93(18):563-72. PubMed ID: 7029926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the clinical significance of acquired antithrombin deficiency.
    Sørum Y; Handeland GF; Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):797-805. PubMed ID: 6083956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin III--an important factor in long-lasting microvascular operations].
    Partecke BD; Fischer C; Buck-Gramcko D
    Handchir Mikrochir Plast Chir; 1985 Mar; 17(2):81-5. PubMed ID: 3988155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early hepatic artery thrombosis after liver transplantation: diagnosis and treatment.
    Nikeghbalian S; Kazemi K; Davari HR; Salahi H; Bahador A; Jalaeian H; Khosravi MB; Ghaffari S; Lahsaee M; Alizadeh M; Rasekhi AR; Nejatollahi SM; Malek-Hosseini SA
    Transplant Proc; 2007 May; 39(4):1195-6. PubMed ID: 17524930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
    Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E
    Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.